Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14665768 | 1.00 | SLC29A1 (0.57) | SLC29A1HIF1A | |
| SCHEMBL12570176 | 0.89 | SLC29A1 (0.49) | SLC29A1HIF1A | |
| SCHEMBL12835761 | 0.89 | SLC29A1 (0.49) | SLC29A1HIF1A | |
| SCHEMBL12570179 | 0.86 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL14175830 | 0.86 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL890292 | 0.86 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL889556 | 0.83 | SLC29A1 (0.61) | SLC29A1HIF1A | |
| SCHEMBL12570175 | 0.83 | SLC29A1 (0.61) | SLC29A1HIF1A | |
| SCHEMBL14666012 | 0.80 | SLC29A1 (0.42) | SLC29A1 | |
| Phosphoric Acid SCHEMBL18044127 | 0.79 | SLC29A1 (0.51) | SLC29A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110287427-A1 | 3'OH-UNBLOCKED, NUCLEOTIDES AND NUCLEOSIDES BASE MODIFIED WITH LABELS AND PHOTOCLEAVABLE, TERMINATING GROUPS AND METHODS FOR THEIR USE IN DNA SEQUENCING | LASERGEN, INC. (US) | 2011-11-24 | — | — | US | disclosed |
| US-20080132692-A1 | Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing | AGILENT TECHNOLOGIES, INC. | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132692-A1 | Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing | UNG, DCLRE1B, NT5C3B | SLC29A1 213/4885HIF1A 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.